Fibroblast growth factor 23 but not copeptin is independently associated with kidney failure and mortality in patients with chronic kidney disease.

Arthur Michon-ColinMarie MetzgerLaura-Gabriela Sánchez-LozadaCédric GauciMélanie BrunelStéphanie BaronCaroline Prot-BertoyeBénédicte StengelEric ThervetJean-Philippe HaymannJean-Jacques BoffaFrançois VrtovsnikMartin FlamantPascal HouillierDominique PrieMarie Courbebaissenull null

Published in: Clinical kidney journal (2023)

Our study shows for the first time in population of CKD patients an independent association between iFGF23 and unfavourable renal and vital outcomes and shows no such association regarding copeptin, encouraging the integration of iFGF23 measurement into the follow-up of CKD.

Keyphrases

chronic kidney disease
end stage renal disease
ejection fraction
newly diagnosed
prognostic factors
cardiovascular events
type diabetes
cardiovascular disease
metabolic syndrome
adipose tissue
skeletal muscle
weight loss